Amgen was founded in 1980 by a group of scientists and venture capitalists in the United States.

Its founder originally worked for Abbott Laboratories.

After the company was established, there was no product on the market.

So they had to rely on issuing shares to raise funds.

Until Gordon Binder took over as CEO in 1988, the company was still small, with only more than 400 employees and no products on the market.

It was not until a year later that Amgen launched its first product, recombinant artificial erythropoietin, which was approved by the FDA in the United States for the treatment of anemia caused by chronic renal failure and anemia caused by HIV infection.

Two years later.

That is, in February 1991, Amgen’s second product, recombinant granulocyte colony-stimulating factor, was mainly used to treat neutropenia caused by tumor chemotherapy.

The emergence of two biological technologies has benefited countless hemodialysis patients and cancer chemotherapy patients, and also brought huge profits to the company, and the company has grown rapidly accordingly.

Today, Amgen is one of the world’s top 500 companies. Last year, its product sales exceeded US$1.2 billion and its market value reached US$2.3 billion.

According to information disclosed by the exchange, Amgen currently has four major shareholders.

They are Dr. Sossi Able, who holds 23% of the shares, Nancy Company, which holds 22%, Johnson & Johnson, which holds 16%, and Perkins Investment Company, which holds 22% of the shares. Twenty percent.

The remaining 19 percent is in the stock market.

According to last year’s financial report, Amgen achieved sales of US$1.2 billion and total net profit of US$280 million, achieving net profit growth for three consecutive years.

The data also shows that Perkins Investment Company’s vision is not very good. So far, the company with the best investment return prospects is Amgen.

As for the other companies that Perkins invested in, most of them are in the stage of losses and bankruptcy.

It can be said that without the income brought by Amgen, I am afraid that Perkins Investment Company would have gone bankrupt.

If Jiang Feng can come up with a price that Perkins Investment Company cannot refuse, I believe Perkins will sell Amgen without hesitation.

The premise is that the price must agree with Perkins’ mental estimate.

Even more than that.

Only in this way will Perkins give up the sweet potato of Amgen.

After reading the information, Jiang Feng called Pearson and convened a meeting of the acquisition team to study the specific acquisition plan.

Jiang Feng scanned everyone’s faces and took the lead in setting the tone:”Everyone must have read the information about the acquisition of Amgen, so I won’t elaborate too much. This time our goal is to invest in Perkins , Bought the shares of Nancy Company”

“The second step is to acquire as much of Sosi Abel’s equity as possible on the basis of completely retaining him!”

The most valuable thing about Amgen is its R&D team leader, Dr. Sossi Abel, the founder of the company. He may not be good at running a company, but he is still very good at R&D products.

He has won the Nobel Prize, and secondly It is his scientific research team and the drug patents that have been developed.

Everything else is not important.

What Jiang Feng wants is his people, patents, and R&D team.

As for other laboratories, production lines, etc., it is not important at all. If you have money, you can always Buy better!

In any company, the most valuable thing is people.

This is even more obvious in companies with a high proportion of scientific research.

Dr. Sossi Abel is such a person.

He is the company’s The core soul figure

“Boss, according to the current market value of Amgen, if we want to fully control it, we may have to spend US$1.4 billion or even US$1.7 billion.”

A subordinate in the acquisition team who was about 35 or 36 years old stood up and said.

Jiang Feng immediately replied:”Money is not an issue. The company’s registered capital is 100 million US dollars, but it does not mean that only 100 million US dollars can be operated. As long as the project is good, Not to mention 1 billion US dollars, even 2 billion or 3 billion US dollars is no problem. This point, everyone needs to keep in mind that the strength of the consortium behind the company is much stronger than you think.”

Blackstone is a completely new structure in the United States. As for the previous group of people in Xiangjiang, they have already left Blackstone and joined Tianhe, Hanhai, and even the Jiang Family Fund Company.

All of these new recruits have He is from the United States, so he doesn’t know the forces behind Blackstone Investment.

Although Jiang Feng has appeared on the cover of Time magazine, he can’t tell the difference just like people in Daxia look at Europeans and Americans.

It’s the same with Europe and America when they look at Daxia. , they all think they look the same.

Besides, it’s been more than a year, and no one knows about it. Jiang Feng’s name is usually reported, and there are very few photos of him. This is mainly because he rarely gives interviews. Inside

“Here, you need to remember that in future investment acquisitions, funding issues are not among the considerations!”

As soon as these words came out, everyone present was excited and realized that the company they joined was not as simple as it seemed on the surface.

But isn’t this better?

In an instant, everyone’s sense of belonging to the company greatly increased.

……

“So the difficulty now is to convince Nancy and Perkins to give up the idea of holding shares in Amgen and then sell their shares to us!”

After everyone discussed, Pearson concluded his speech:

“Boss, I think there are two groups of people at the moment. Perkins is not a big problem. Their company’s debt situation is not very good. I think as long as our offer is suitable, they will not refuse. However, this Nancy Company is a company of Reese. I suggest exploring the area first to see what they think before deciding.”

After saying that, everyone turned their attention to Jiang Feng.

This was exactly what Jiang Feng wanted. He nodded and said,”Well, just do what you said, divide into three groups, and I’ll go talk to Dr. Soxy Abel. Talk, which one of you is going to talk to Perkins and Nancy?”

“I!”

“Boss, I’m willing to go”

“……..”

Suddenly several people rushed to say.

Jiang Feng raised his lips slightly, and after letting several people explain their ideas, he selected one of them with a better idea to be the acquisition team leader.

Others were assigned to three groups.

Jiang Feng led the team to talk to Dr. Sossi Abel, while Pearson went to talk to Perkins in person. The newly elected leader of the acquisition team was named Walter, who will be responsible for the acquisition of Nancy Company.

After that, several more meetings were held to come up with a complete acquisition plan and an independent action plan.

January 8th.

Jiang Feng called everyone to gather in the company conference room, boosted morale, and then announced the action.

The three acquisition teams were dispatched at the same time, heading towards the three companies……..

Among the three groups, Jiang Feng was responsible for talking to Dr. Soxy Abel.

This is a scientific research expert. At first, he just wanted to open a laboratory to study his biotechnology. However, he did not expect that later, under the instigation of his friends and wanting to use venture capital money to promote research and development, he entered into a partnership with Several companies jointly established Jingjing Company.

Because they had made an appointment in advance, Jiang Feng and others were led by the reception staff to meet Dr. Sossi Abel.

Seeing Jiang Feng’s team of five people, with a young yellow man as the core, Suoxi Abel’s eyes narrowed, and several thoughts flashed through his mind.

He has also heard about Blackstone Investment.

It is said to be a venture capital firm established less than three years ago and has invested in some small startups in Silicon Valley.

I thought he was American.

I didn’t expect him to be a yellow man.

After a slight loss of composure, Suoxi Abel soon said with a polite face:”Mr. Jiang, it’s an honor to meet you and welcome you!”

Jiang Feng smiled slightly,”Thank you, Mr. Suoxi, for your warm hospitality!”

……

“Mr. Jiang, I wonder what I can do for you when you come this time?”After the greetings, Suoxi Abel was not polite, and went straight to the topic and asked Jiang Feng about his purpose.

Jiang Feng smiled slightly and said,”I came here mainly because I want to discuss a deal with Suoxi. I have something. A drug, the patent right has been applied for, and now someone needs to take the lead in development and clinical trials. It is said that Amgen has experience in this area, so I want to cooperate with your company to develop this drug.”

“oh? Suo

Xi became interested and asked curiously,”What kind of treatment does the medicine you mentioned treat?”

Jiang Feng smiled and said unhurriedly:”There are several. One of them can treat severe active rheumatoid arthritis in middle-aged and elderly people, improve function, and can also treat adult patients with severe active ankylosing spondylitis.”…It can also have a certain therapeutic effect on psoriasis…”

“The other is a recombinant humanized monoclonal antibody that can inhibit tumor blood vessels….”

Suo Xi’s faint smile couldn’t help but move.

By the end, he was no longer calm.

My breathing became much faster.

Looking closely at Jiang Feng, after Jiang Feng finished speaking, he immediately asked:”Mr. Jiang, is what you said true? Really?���to inhibit tumor blood vessels…”

Jiang Feng said in a positive tone:”Of course…However, these still need some clinical verification, so I hope to strengthen cooperation with Amgen.”

“So how do you want to collaborate? Suo Xi asked hurriedly.

Jiang Feng smiled slightly and said:”We hold shares in each other. I hope to buy the shares of Amgen in your hands, Doctor. On the contrary, after buying them, I will give shares to the new company, or if you are willing Exchange the money for shares in the new company.”

New company?

Suo Xi was stunned.

Then he thought of something.

His face changed, his eyes widened, and he looked at Jiang Feng in surprise,”You want to acquire Amgen?”

Jiang Feng smiled, noncommittal.

Hiss.

Suo Xi took a breath of air.

He looked at Jiang Feng carefully for a few times, and then said slowly:”I guess Mr. Jiang is not only the boss of Blackstone Investment Company, but also someone else. Some other identity?”


Tap the screen to use advanced tools Tip: You can use left and right keyboard keys to browse between chapters.

You'll Also Like